Related MeSH Hierarchy (5)
Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Cardiotoxicity
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Cardiotoxicity
Diseases [C] » Chemically-Induced Disorders [C25] » Drug-Related Side Effects and Adverse Reactions » Cardiotoxicity
Diseases [C] » Wounds and Injuries [C26] » Radiation Injuries » Cardiotoxicity
Phenomena and Processes [G] » Physical Phenomena [G01] » Radiation » Radiation Exposure » Radiation Injuries » Cardiotoxicity
Description
Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION. MeSH
Hierarchy View
Phase 4 Indicated Drugs (6)
Phase 3 Indicated Drugs (29)
Phase 2 Indicated Drugs (8)
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (20)
Organization Involved with Phase 2 Indications (18)
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (5)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
